Drug & Device Development
06-10-2010
Yttrium-90 radioembolization effective for neuroendocrine liver metastases
06-07-2010
Delcath sends melphalan directly into liver via hepatic artery
05-25-2010
Telaprevir achieves 75% rate of sustained HCV response: study
05-05-2010
Telaprevir improves sustained response rates in refractory HCV
04-29-2010
Octreotide shrinks polycystic livers and kidneys
04-21-2010
Metastatic melanoma trial meets main goal
New compound potent against hepatitis C
04-16-2010
Gilead drug effective against liver disease: study
03-31-2010
Pegylated arginine deiminase has potential for unresectable hepatoma
02-24-2010
New hepatitis C drug shows good response in early trial
12-24-2009
Angiographic subsegmentectomy safe and effective for small liver tumors
12-03-2009
Hepatitis C drug fights virus in new way
08-18-2009
Sinovac says one-shot swine flu vaccine effective
08-14-2009
Glaxo starts testing flu pandemic vaccine
05-14-2009
Novel anti-HBV vaccine may prevent hepatocellular carcinoma
04-09-2009
AMD11070 shows action against X4-tropic HIV
03-09-2009
Human Genome hepatitis C drug disappoints, shares crash
2008
2007
2006
2005
2004
12-25-2008
Silibinin infusion has antiviral effect against HCV in nonresponders
11-03-2008
Therapeutic hepatitis C vaccine shows benefit in phase 2 trial
08-22-2008
Silymarin prevents antituberculosis drug-related hepatotoxicity in rats
06-30-2008
Peptide vaccine shows some promise in hard-to-treat HCV
06-03-2008
IKK2 inhibition blocks liver steatosis in mice
04-30-2008
Radioembolization promising for inoperable chemorefractory liver metastases
